lysophosphatidic acid has been researched along with Carcinoma, Endometrioid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariztia, EV; Boyd, LR; Fishman, DA; Hetherington, JA; Horton, FR; Smicun, Y; Smith, PJ; Wang, FQ | 1 |
1 other study(ies) available for lysophosphatidic acid and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Topics: Carcinoma, Endometrioid; Cell Growth Processes; Cell Line, Tumor; Endometrial Neoplasms; Enzyme Activation; Female; Fibrosarcoma; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Matrix Metalloproteinases; Neoplasm Invasiveness; RNA, Messenger | 2010 |